G
Groundwork BioAg
Produces mycorrhizal inoculants for commercial agriculture
About Groundwork BioAg
GroundWork BioAg is a pioneering bioagriculture startup based in Mazor, Israel, specializing in the development and commercialization of mycorrhizal inoculants. These inoculants are beneficial fungi that form symbiotic relationships with plant roots, enhancing nutrient uptake and improving crop yields. The company primarily serves commercial agriculture clients, including farmers and agribusinesses, who are looking to increase productivity and sustainability in their operations.
Read full description
Operating in the global agricultural market, GroundWork BioAg employs a business-to-business (B2B) model. The company generates revenue by selling its mycorrhizal inoculants directly to agricultural producers and through partnerships with distributors and agricultural input suppliers. By focusing on sustainable agriculture, GroundWork BioAg addresses the growing demand for eco-friendly farming solutions that reduce dependency on chemical fertilizers and improve soil health.
GroundWork BioAg's team is composed of experts in agriculture, biology, and marketing communications, all dedicated to advancing sustainable farming practices. The company leverages cutting-edge research and development to continuously innovate and improve its product offerings, ensuring they meet the evolving needs of the agricultural sector.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Mazor, Israel
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 83.8/100
- Sub-industry
- AgriTech, Innovative Food
- Sector
- Food, Farming, Biotechnology, Spinout, Crop, Alternative Protein, Sustainable Development Goals, Mycelium Technology, Regenerative Agriculture, Climate Tech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Jan 2024 | $0 | — | BIRD Foundation | ↗ |
| SERIES B✓Equity / VC | Aug 2022 | $18M | $72M | Ibex Investors · John Abele · MoreVC · Middleland Capital | ↗ |
Growth signals
Latest recorded traffic for Groundwork BioAg is 8.7K monthly website visits, up 128.9% over the last three months. Groundwork BioAg's team grew 10.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
BIRD Foundation
Series A6 investors entered at this stage
Middleland Capital
Climate Innovation Capital
John Abele
BASF Venture Capital
HSBC Asset Management
Edaphon
Series B and later6 investors entered at this stage
MoreVC
ProDelta
Future Foodways- AVAxess Ventures
Ibex Investors- BABPD Agri
Other known investors4 additional known investors
Volcani Institute- AVAdi Vagman
Meach Cove Capital
PI Impact
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Groundwork BioAg on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Groundwork BioAg’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.